LEXINGTON, Mass., May 5 Indevus Pharmaceuticals,Inc. (Nasdaq: IDEV) announced positive results of the ongoing Phase IIIextension study of SUPPRELIN(R) LA (histrelin acetate), the only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results